Literature DB >> 18562638

Structural basis for controlling the dimerization and stability of the WW domains of an atypical subfamily.

Satoshi Ohnishi1, Naoya Tochio, Tadashi Tomizawa, Ryogo Akasaka, Takushi Harada, Eiko Seki, Manami Sato, Satoru Watanabe, Yukiko Fujikura, Seizo Koshiba, Takaho Terada, Mikako Shirouzu, Akiko Tanaka, Takanori Kigawa, Shigeyuki Yokoyama.   

Abstract

The second WW domain in mammalian Salvador protein (SAV1 WW2) is quite atypical, as it forms a beta-clam-like homodimer. The second WW domain in human MAGI1 (membrane associated guanylate kinase, WW and PDZ domain containing 1) (MAGI1 WW2) shares high sequence similarity with SAV1 WW2, suggesting comparable dimerization. However, an analytical ultracentrifugation study revealed that MAGI1 WW2 (Leu355-Pro390) chiefly exists as a monomer at low protein concentrations, with an association constant of 1.3 x 10(2) M(-1). We determined its solution structure, and a structural comparison with the dimeric SAV1 WW2 suggested that an Asp residue is crucial for the inhibition of the dimerization. The substitution of this acidic residue with Ser resulted in the dimerization of MAGI1 WW2. The spin-relaxation data suggested that the MAGI1 WW2 undergoes a dynamic process of transient dimerization that is limited by the charge repulsion. Additionally, we characterized a longer construct of this WW domain with a C-terminal extension (Leu355-Glu401), as the formation of an extra alpha-helix was predicted. An NMR structural determination confirmed the formation of an alpha-helix in the extended C-terminal region, which appears to be independent from the dimerization regulation. A thermal denaturation study revealed that the dimerized MAGI1 WW2 with the Asp-to-Ser mutation gained apparent stability in a protein concentration-dependent manner. A structural comparison between the two constructs with different lengths suggested that the formation of the C-terminal alpha-helix stabilized the global fold by facilitating contacts between the N-terminal linker region and the main body of the WW domain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562638      PMCID: PMC2525516          DOI: 10.1110/ps.035329.108

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  26 in total

1.  Latent and active p53 are identical in conformation.

Authors:  A Ayed; F A Mulder; G S Yi; Y Lu; L E Kay; C H Arrowsmith
Journal:  Nat Struct Biol       Date:  2001-09

2.  Automated NMR structure calculation with CYANA.

Authors:  Peter Güntert
Journal:  Methods Mol Biol       Date:  2004

3.  Solution structure of an atypical WW domain in a novel beta-clam-like dimeric form.

Authors:  Satoshi Ohnishi; Peter Güntert; Seizo Koshiba; Tadashi Tomizawa; Ryogo Akasaka; Naoya Tochio; Manami Sato; Makoto Inoue; Takushi Harada; Satoru Watanabe; Akiko Tanaka; Mikako Shirouzu; Takanori Kigawa; Shigeyuki Yokoyama
Journal:  FEBS Lett       Date:  2007-01-16       Impact factor: 4.124

4.  Determinants of ligand specificity in groups I and IV WW domains as studied by surface plasmon resonance and model building.

Authors:  Yusuke Kato; Mie Ito; Kunji Kawai; Koji Nagata; Masaru Tanokura
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

Review 5.  Structure and function of the WW domain.

Authors:  M Sudol
Journal:  Prog Biophys Mol Biol       Date:  1996       Impact factor: 3.667

6.  Structural genomics projects in Japan.

Authors:  S Yokoyama; H Hirota; T Kigawa; T Yabuki; M Shirouzu; T Terada; Y Ito; Y Matsuo; Y Kuroda; Y Nishimura; Y Kyogoku; K Miki; R Masui; S Kuramitsu
Journal:  Nat Struct Biol       Date:  2000-11

7.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

8.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

9.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

10.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.

Authors:  N A Farrow; R Muhandiram; A U Singer; S M Pascal; C M Kay; G Gish; S E Shoelson; T Pawson; J D Forman-Kay; L E Kay
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

View more
  5 in total

Review 1.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

2.  Recombinantly produced hydrophobins from fungal analogues as highly surface-active performance proteins.

Authors:  Wendel Wohlleben; Thomas Subkowski; Claus Bollschweiler; Bernhard von Vacano; Yaqian Liu; Wolfgang Schrepp; Ulf Baus
Journal:  Eur Biophys J       Date:  2009-03-17       Impact factor: 1.733

3.  Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation.

Authors:  Eung Ju Kim; Baek-hui Kim; Hong Seog Seo; Yong Jik Lee; Hyun Hee Kim; Hyun-Hwa Son; Man Ho Choi
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

4.  Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain.

Authors:  Keijun Kakihara; Kengo Asamizu; Kei Moritsugu; Masahide Kubo; Tetsuya Kitaguchi; Akinori Endo; Akinori Kidera; Mitsunori Ikeguchi; Akira Kato; Masayuki Komada; Toshiaki Fukushima
Journal:  Commun Biol       Date:  2021-11-08

5.  Changes in the folding landscape of the WW domain provide a molecular mechanism for an inherited genetic syndrome.

Authors:  Encarna Pucheta-Martinez; Nicola D'Amelio; Moreno Lelli; Jorge L Martinez-Torrecuadrada; Marius Sudol; Giorgio Saladino; Francesco Luigi Gervasio
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.